An interventional study of Contact information and Urgent care map in Behavior, Health, sponsored by Geisinger Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-26.
Sponsored by Geisinger Clinic · Not applicable, Interventional, and Prevention
Decreasing utilization of the Emergency Department (ED) is a priority for the system. Often, ED visits can be avoided if patients contact Geisinger first to get appropriate direction for their concern or are otherwise better informed about reasons to visit the ED vs. urgent care or primary care facilities. The study team is working to reduce ED utilization by including additional information in adult outpatient After Visit Summaries (AVSs). The study will involve will involve A/B testing different AVS versions, including 1) a version that encourages patients to contact Geisinger via different contact methods, 2) a version that includes a map to the patient's closest ConvenientCare location and accompanying information about ConvenientCare, and 3) a version that includes a self-triage guide. A control group will receive the current standard AVS. Analysis results will be assessed to determine which version is most effective at reducing ED use.
1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.
This study's enrollment of 239,841 is above the median of 145 across 931 interventional studies indexed under Emergencies.
Browse Emergencies studies →Geisinger Clinic is the lead sponsor of 125 studies on the registry; 21 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients in this arm will receive the current standard practice AVS.
Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention.
Behavioral: Contact information
Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care.
Behavioral: Contact information · Behavioral: Urgent care map
Patients in this arm will receive the standard AVS, plus information on how to contact Geisinger if they need medical attention, plus a map to their nearest Geisinger urgent care location and additional information about urgent care. This arm will also receive a self-triage chart, with common reasons patients go to the ED and situations where seeking alternative care might be appropriate.
Behavioral: Contact information · Behavioral: Urgent care map · Behavioral: Self-triage chart
Information on how to contact Geisinger if the patient needs care
A map of the patient's nearest Geisinger urgent care location, with information about urgent care
A chart demonstrating what to do in response to several common conditions where the patient might be compelled to visit the ED
Inappropriate ED visits
Visited the ED inappropriately (y/n) We will apply the NYU algorithm (Ballard et al., 2010) to determine whether an ED visit is inappropriate.
Time frame: In the 30 days following the appointment
Urgent care visits
Visited urgent care (y/n)
Time frame: In the 30 days following the appointment
Calls
Called Geisinger (y/n)
Time frame: In the 30 days following the appointment
Patient portal messages
Sent a patient portal message (y/n)
Time frame: In the 30 days following the appointment
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.
Supporting information: Study protocol, Sap, Analytic code
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Geisinger Clinic